Necla Eren TÜLEK, Prof Dr

1- Fisgin NT, Doganci L, Tanyel E, Tulek N. Initial High Rate of Misdiagnosis in Crimean Congo Hemorrhagic Fever Patients in Endemic Region-in Turkey. 48 th Annual ICAAC/IDSA 46 th Meeting, Washington, DC, 25-28 October. V-1657 (Internet aracılı alındığı için kitapçık kapağı verilememiştir).
2- Fisgin NT, Doganci L, Ergonul O, Tulek N. Early Ribavirin Use in Crimean-congo Hemorrhagic Fever: Significant Positive Impact in Prognosis. 48 th Annual ICAAC/IDSA 46 th Meeting, Washington, DC, 25-28 October. V-1658 (Internet aracılı alındığı için kitapçık kapağı verilememiştir).
3- Kutlu G, Ertem GT, Coşkun O, Ergun U, İnan LE, Tulek N. Brucellosis: A cause of peripheral neuropathy. 18th ECCMID Barcelona 19-22 April 2008 (yurt dışı yayın)
4- Bulut C, Yetkin MA, Erdinc FS, Yilmaz GR, Yücel M, Tülek N, Karakoc EA. Hospital-acquired bloodstream infections in a teaching hospital: a five year follow-up .17th European Congress of Clinical Microbiology and Infectious Diseases,25th International Congress of Chemotherapy 31 March- 3 April 2007 Munich R. 2265. Int J Antimicrobial Agents 29S656-S656 2007.
5- Yetkin MA, Bulut C, Çaydere M, Erdinc FS, Ertem G, Kinikli S, Tülek N, Üstün H, Demiroz AP. Aspartate aminotransferase to platelet ratio index for the evaluation of fibrosis in chronic viral hepatitis Abstract number: P.1879. European Congress of Clinical Microbiology and Infectious Diseases,25th International Congress of Chemotherapy 31 March- 3 April 2007 Int J Antimicrobial Agents 29S538-S538 2007.
6- Bulut C, Yetkin MA., Erdinc FS, Ataman Hatipoglu C, Onde U, Karakoc EA, Tülek N. Assessment of the risk factors for mortality in hospital-acquired Acinetobacter baumannii infections in a teaching hospital Abstract number: 1733_1432 European Congress of Clinical Microbiology and Infectious Diseases/25th International Congress of Chemotherapy 31 March- 3 April 2007 R 1936f Int J Antimicrobial Agents 29S556-S556 2007.
7- Ataman Hatipoğlu Ç, Yetkin MA, Ergin F, İpekkan K, Erdinç FŞ, Bulut C, Tülek N, Demir G, Yiğit Y, Demiröz AP. Vaccination of healthcare workers against hepatitis B virus in a teaching hospital. European Congress of Clinical Microbiology and Infectious Diseases/25th International Congress of Chemotherapy 31 March- 3 April 2007 R 1936 Int J Antimicrobial Agents 29S90-S290 2007
8- Fışgın NT, Tanyel E, Tulek N. Risk factors among patients with Crimean Congo haemorrhagic fever. European Congress of Clinical Microbiology and Infectious Diseases/25th International Congress of Chemotherapy 31 March- 3 April 2007 Int J Antimicrobial Agents 29S280-S280 2007
9- Kaya Firat S, Oral B, Erdinc FS, Yetkin MA, Tulek N, Demiröz AP. In vitro activity of antimicrobial agent combinations against Brucella melitensis by E-test.16 th Eurpean Congress of Clinical Microbiology and Infectious Diseases 1-4 April 2006, Nice/ Abstract: P1293 Clinical Microbiology and Infection Volume 12 Suppl 4; 2006
10- Yetkin MA, Bulut C, Yilmaz GR, Erdinc FS, Kinikli S, Oral B, Tulek N, . Demiroz AP. Epidemiological features and clinical manifestations of adult brucellosis in Turkey 16 th Eurpean Congress of Clinical Microbiology and Infectious Diseases 1-4 April 2006, Nice/France : P851 Clinical Microbiology and Infection Volume 12 Suppl 4; 2006.
11- Iseri S, Bulut C, Irmak H, Yetkin MA, Kinikli S, Tulek N, Demiröz AP.Comparison of the blood and bone marrow culture positivity rates for the diagnosis of brucellosis Abstract: P1738 16 th Eurpean Congress of Clinical Microbiology and Infectious Diseases 1-4 April 2006, Nice/ Abstract: P1293 Clinical Microbiology and Infection Volume 12 Suppl 4; 2006.
12- Tekin Koruk S, Yetkin MA, Koruk I, Erdinc FS, Sahan S, Tulek N, Duranay M, Demiröz AP.Evaluation of continuous ambulatory peritoneal dialysis-related peritonitis attacks in Ankara Abstract: P187416 th Eurpean Congress of Clinical Microbiology and Infectious Diseases 1-4 April 2006, Nice/ Abstract: P1293 Clinical Microbiology and Infection Volume 12 Suppl 4; 2006
13- Coban AY, Tanyel E, Tasdelen Fisgin N, Darka O, Tulek N, Durupinar. B. Mutant prevention concentrations of ciprofloxacin for Brucella melitensisAbstract: R1919 ECCMID16 th Eurpean Congress of Clinical Microbiology and Infectious Diseases 1-4 April 2006, Nice/ Clinical Microbiology and Infection Volume 12 Suppl 4; 2006 .
14- Tanyel E, Coban AY, Tekin Koruk S, Hepsert S, Cirit O, Simsek H, Tulek N .In vitro susceptibility of Brucella melitensis to antibioticsAbstract: R196816 th Eurpean Congress of Clinical Microbiology and Infectious Diseases 1-4 April 2006, Nice/ Clinical Microbiology and Infection Volume 12 Suppl 4; 2006.
15- Sahan S, Ataman Hatipoglu C, Bulut C, Tekin Koruk S, Tuncer Ertem G, Tulek N, Kinikli S, Demiroz AP. Quality of life in brucellosis 16 th Eurpean Congress of Clinical Microbiology and Infectious Diseases 1-4 April 2006, Nice/FranceAbstract: R2092 .
16- Aydin B, Tanyel E, Colak B, Fisgin N. Tulek N.Infection control practice in forensic medicineAbstract: R2108 16th Eurpean Congress of Clinical Microbiology and Infectious Diseases 1-4 April 2006, Nice/ ECCMIDClinical Microbiology and Infection Volume 12 Suppl 4; 2006.
17- Erdinç FS, Yetkin MA, Hatipoğlu ÇA, Yücel M, Karakoç AE, Çevik MA, Tülek N. Five yeara surveillance of nosocomial infectons in a training and research hospital in Ankara. Clin Microbiol And Infect 2005 Volume 11, Suppl 2, P:681 R 2048 .
18- Bulut C, Gökçek C, Ertem G, Erdem Y, Bayer MA, Karakoç E, Tulek N. A rare cause of wound infection: Shewanella putrefaciens.14th European Congress of Clinical Microbiology and Infectious Diseases Prague, Czeck Republic 1-4 May 2004 CMI (10(3), 2004, P:1664 (makalesi var).
19- Coskun O, Tuncer Ertem G, Ergun U, Kutlu G, Tulek N, İnan LE, Ozkan S. evaluation of brain-stem auditory potential in brucellosis patients with and without neurobrucellosis. 14th European Congress of Clinical Microbiology and Infectious Diseases Prague, Czeck Republic 1-4 May 2004 CMI (10(3), 2004, R2041 (makalesi var).
20- Hatipoğlu CA, Bilgin G, Tülek N, Koşar U. Pulmonary involvement in brucellosis. 14th European Congress of Clinical Microbiology and Infectious Diseases Prague, Czeck Republic 1-4 May 2004 CMI (10(3), 2004, P:474 (makalesi var).
21- Tuncer Ertem G, Ataman Hatipoğlu Ç, Tülek N. Same involvement in two brothers: epididymoorchitis. 14th European Congress of Clinical Microbiology and Infectious Diseases Prague, Czeck Republic 1-4 May 2004 CMI (10(3), 2004, P:475.
22- Bulut C, Tekiner A, Yetkin MA, Hatipoğlu ÇA, Buharali Z, Tülek N. Evaluation of postneurosurgical nosocomial meningitis in adults. 14th European Congress of Clinical Microbiology and Infectious Diseases Prague, Czeck Republic 1-4 May 2004 CMI (10(3), 2004, P:879.
23- Turan H, Balcı U, Erdinc FS, Tulek N, Germiyanoğlu C. Postintervention frequency of bacteriuria, pyuria and bacteremia in outpatients with who have undergone cystouretroscopy. 13th Europen Congress of Clinical Microbiology and Infectious Diseases. 10-13 May 2003, Glasgow, UK. Clin Microbiol Infect Vol 9, Suppl 1, 2003 P5110 (makalesi var).
24- Tulek N, Şenocak H, Yetkin MA, Un H, Aylan O.Rabies antibody response achieved by different rabies prophylaxis methods. 13th Europen Congress of Clinical Microbiology and Infectious Diseases. 10-13 May 2003, Glasgow, UK. Clin Microbiol Infect Vol 9, Suppl 1, 2003, P:208.
25- Tulek N, Hatipoğlu CA, Yetkin MA. An unusual cause of spontaneous bacterial peritonitis: Brucella melitensis.. 13th Europen Congress of Clinical Microbiology and Infectious Diseases. 10-13 May 2003, Glasgow, UK. Clin Microbiol Infect Vol 9, Suppl 1, 2003 P:322
26- Tulek N, Şimşek H, Erdenlig S, Oral B. Identification and biotyping of Brucella spp isolated from humans in Central Anatolia. 13th Europen Congress of Clinical Microbiology and Infectious Diseases. 10-13 May 2003, Glasgow, UK. Clin Microbiol Infect Vol 9, Suppl 1, 2003 P:325 (makalesi var)
27- Yetkin MA, Simsek H, Tulek N, Dogancı L. Hematological manifestations of brucellosis 12th European Congress of Clinical Microbiology & Infectious Diseases, Milan Italy 21-24 April 2002 Clin Microbiol and Infection Vol. 8 Suppl 1, 2002 P.375.
28- Tumturk A, Yetkin MA, Tulek N, Kılıç D, Doğancı L. Specific ELISA IgM and IgG antibodies for the detection of active brucellosis. 12th European Congress of Clinical Microbiology & Infectious Diseases, Milan Italy 21-24 April 2002 Clin Microbiol and Infection Vol. 8 Suppl 1, 2002 P.377. (makalesi var)
29- Yetkin MA, Tanyel E, Tülek N, Doğancı L. Cutaneous anthrax as an occupational disease in Central Anatolia, Turkey. 12th European Congress of Clinical Microbiology & Infectious Diseases, Milan Italy 21-24 April 2002 Clin Microbiol and Infection Vol. 8 Suppl 1, 2002 P.387
30- Yetkin MA, Erdinç FŞ, Çevik MA, Tümtürk A, Tülek N. Complication rate and significance of serum C-Reactive Protein levels in Brucellosis Cases. 11th European Congress of Clinical Microbiology & Infectious Diseases 1-4 April 2001- İstanbul
31- Yılmaz GR, Çevik MA, Erdinç FŞ, Tülek N. Nosocomial infection surveillance in a neurology intensive care unit. 11th European Congress of Clinical Microbiology & Infectious Diseases 1-4 April 2001- İstanbul.(makalesi var)
32- Yetkin A, Aktaş F, Arman D, Tulek N. Comparision of the IFA and other staining methods for the detection of Crptosporodium oocysts 10th European Congress of Clinical Microbiology and Infectious Diseases Stockholm, Sweden 28-31 May 2000 Clin Microbiol Infect Vol. 6 Supp 1 2000. P.80.
33- Kılıç D, Tekin S, Tuncer G, Tulek N, Doğancı L, Willke A. Antimicrobial drug susceptibility and extended spectrum beta-lactamasa(ESBL) production of Salmonella spp and Shigella spp isolated from community acquired infections in Turkey . 10th European Congress of Clinical Microbiology and Infectious Diseases Stockholm, Sweden 28-31 May 2000 Clin Microbiol Infect Vol. 6 Supp 1 2000. P:81 (makalesi var)
34- Aliefendioglu D, Erdem G, Tulek N, Yurdakok M. Neonatal and maternal serum levels of soluble ICAM-1 in normal and preeclamptic pregnancies.. J Invest Med 48 (5): 93 SEP 2000 (makalesi bulunmaktadır). Bul
35- Tulek N, Şengül A. The distrubition of HLA in Turkish population. 13th European Histocompatibility Conference 13-17 April 1999, Creta, Greece Abstracts P:35.
36- Cengizlier MR, Demirpolat E, Tülek N, Tomaç N. Soluble intercellular adhesin molecule-3 levels in children with bronchial asthma and the effect of inhalated glucucorticoids.The annual meeting of the European Academy of Allergology and Clinical Immunology.EAACI, 99, Eur J Allergol Clin Immunol Suppl 1999.
37- Dalgıç A, Sert S, Tülek N, Ergül Z, Bulut A. HBsAg positive cadaveric renal transplantation to HBsAb-negative recipients in specific circumstances. Fourteenth National Congress of KidneyDiseases, Dialysis and Transplantation 10-14 November 1997, Antalya, Turkey Nephrol Dial Transplant(1998) 13; 2431-2432.
38- Cengizlier R, Çalışkol S, Vidinlisan S, Tülek N. Glucagon in the treatment of acute bronchial asthma in children. The annual meeting of the European Academy of Allergology and Clinical Immunology.EAACI, 97, Birmingham U.K. June 1-5, 1997. Eur J Allergol Clin Immunol Suppl 1997; 52(37), 136
39- Cakar N, Tulek N, Atakan C, Kocak H. The importance of HLA antigens in Turkish patients with familial Mediterranean fever. Hum Immunol 47 (1-2): P182-P182 APR 15 1996.
40- Cengizlier R, Çakar N, Tülek N, Koçak H.. Minimal Change Nephrotic Syndrome (MCNS) and Allergy. Annual Meeting of The European Academy of Allergology and Clinical Immunnology EAACI'96.Eur J Aller Clin Immunol Suppl 1996: 51(31) ; 182.
41- Cengizlier R, Uygurçetin T, Tülek N, Fırat S, Vidinlisan S. The role of nasal cytology in the diagnosis of chronic sinusitis in atopic children. Annual Meeting of The European Academy of Allergology and Clinical Immunology EACCI'96 Budapest 2-5 June 1996 Eur J Aller Clin Immunol Suppl . 1996: 51(31) ; 136.
42- Tülek N, Cengizlier R, Erhan M, Mert A.Latex allergy in a high risk group. XVI European Congress of Allergology and Clinical Immunology , 25-30 June, 1995, Madrid, Spain. Eur J Aller Clin Immunol ,1995: 50(26) Suppl;P:178 (makalesi var)
43- Kınıklı G, Tülek N, Serçelik A, Tutkak H, Turgay M, Duman M, Tokgöz G. The change of serum interleukin-2 receptor levels during early phase of immunotherapy of patients with allergic rhinoconjunctivitis. XVI European Congress of Allergology and Clinical Immunology, 25-30 June 1995, Madrid, Spain, Eur J Aller Clin Immunol ,1995: 50(26)26 Suppl P0580. (makalesi var)
44- Tülek N, Aydıntuğ O, Tokgöz G, Düzgün N, Tutkak H. Lyme serology in Turkish Patients with unclassified arthritis. 13th Congress of the European Association of Internal Medicine.Athens,October 4th-7th 1995.(makalesi var).
45- Kınıklı G, Tülek N, Ataman Ş, Turgay M, Tutkak H, Tokgöz G, Duman M, Düzgün N, Ölmez Ü. The early effect s of specific immunotherapy on lymphocyte response to PHA and allergens in atopic patients with allergic rhino conjunctivitis. XV International Congress of Allergology and Clinical Immunology, June26-July 1,1994, Stockholm, Sweden Aller Clin Immunol News.1994 ;Suppl. 2; 829 (makalesi var).
46- Aydıntuğ O, Tülek N, Tutkak H, Özoran K, Düzgün N, Duman M, Tokgöz. G. Soluble intercellular adhesion molecule-1(sICAM-1) in patients with Systemic Lupus Erythematosus. Fourth Breton Workshop on Autoimmunity,BREST, 15-16/4/1994 (makalesi var).
47- Kınıklı G, Tülek N, Turgay M, Şengül A, Tutkak H, Tokgöz G.Lymphocyte transformation by allergen and mitogen. Annual Meeting of European Academy of Allergology and Clinical Immunology, 12-15 September, 1993, Rotterdam, Netherland . Eur J Aller Clin Immunol,1993 48(16) suppl P1328.
48- Sengül A, Tutkak H, Tülek N, Özoran K, Düzgün N, Gürler A, Tokgöz G. Tumor necrosis factor-alpha and interleukin-6 levels in Behçet's Disease.6th International Conference on Behçet's Disease. June 30-July 1 Paris,France-1993La Revue de Medecine Interne, 1993: 14 Suppl 1; p134.(kitapçıkta var)